Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5‐hydroxytryptaminergic neurones. Studies with fenfluramine.

A. Quattrone, G. Tedeschi, U. Aguglia, F. Scopacasa, GF Direnzo, L. Annunziato

Research output: Contribution to journalArticlepeer-review

Abstract

Acute oral administration of various doses of fenfluramine, a 5‐HT releaser, induced a dose‐related increase of PRL secretion in nine healthy volunteers. Fenfluramine reached the maximum effect on PRL secretion at 4 h after its administration. This effect was already significant at 2 h and lasted till 8 h. Metergoline, a 5‐HT receptor blocker, when administered alone, decreased serum PRL levels in six healthy subjects. The pretreatment with this drug significantly antagonized the PRL‐releasing action of fenfluramine (60 mg) suggesting that the effect of fenfluramine on PRL release may be mediated through a 5‐HT mechanism in the brain. These findings suggest the possibility that serum PRL levels in humans may represent a useful tool to evaluate, in vivo, the activity of drugs possessing putative 5‐ hydroxytryptaminergic properties. 1983 The British Pharmacological Society

Original languageEnglish
Pages (from-to)471-475
Number of pages5
JournalBritish Journal of Clinical Pharmacology
Volume16
Issue number5
DOIs
Publication statusPublished - 1983

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5‐hydroxytryptaminergic neurones. Studies with fenfluramine.'. Together they form a unique fingerprint.

Cite this